Skip to main content
. 2014 Feb 1;12(1):55–79. doi: 10.1089/adt.2013.524

Table 5.

Confirmation of the Library of Pharmacologically Active Compounds and National Institutes of Health Clinical Collection Primary pSTAT3 High-Content Screening Actives

Compound information % Inhibition of IL-6-induced pSTAT3-Y705 % Inhibition of IFNγ–induced pSTAT1-Y701
SID SL Name HCS Mean 24 h SD Mean 1 h SD Mean 24 h SD Mean 1 h SD
46386661 N Azelastine 82.6 90.4 4.8 96.2 14.5 24.2 18.1 29.6 41.4
53777461 L Dihydroouabain 97.8 84.2 6.2 4.7 16.9 81.3 8.0 −55.5 19.0
53777973 L NF449 octasodium salt 85.2 72.6 5.2 96.9 2.7 90.3 7.8 96.1 1.4
46386563 N Desloratadine 72.9 72.0 1.5 111.3 1.0 27.4 22.2 73.5 8.5
53778225 L SB 205384 85.0 69.8 7.0 56.6 2.8 89.2 1.4 25.4 1.1
53778026 L Phenylephrine hydrochloride 51.6 69.5 4.7 85.4 1.3 40.2 4.6 75.9 5.3
53778265 L Trazodone hydrochloride 53.5 68.2 4.5 72.0 3.9 35.7 12.4 50.5 15.2
46387007 N R(+)-SCH-23390 HCl 63.4 66.4 5.5 77.1 2.5 30.5 23.8 65.6 3.1
53778017 L Nylidrin hydrochloride 59.8 66.1 8.7 72.4 3.6 20.7 12.0 45.7 16.9
53778204 L Albuterol hemisulfate 60.2 63.5 2.3 102.8 2.1 20.9 9.0 94.0 1.7
53777777 L Isotharine mesylate 52.1 59.1 9.5 23.0 2.3 −11.0 5.5 −29.6 13.2
53777593 L Forskolin 75.2 57.2 4.8 91.3 1.8 3.8 9.6 84.4 3.5
46386983 N Etomidate 61.3 56.7 7.1 65.8 8.1 17.1 22.3 13.4 7.8
53777746 L R(−)-Isoproterenol (+)-bitartrate 64.4 56.1 1.8 52.8 4.8 27.0 5.2 44.6 12.2
53777650 L Fenoterol hydrobromide 61.5 56.0 10.0 107.5 1.7 7.5 16.2 97.0 1.2
46386731 N Cefpodoxime proxetil 55.1 54.6 1.1 99.0 3.3 13.1 18.6 94.0 2.7
53778255 L Tulobuterol hydrochloride 57.5 53.0 11.4 60.6 5.6 22.6 8.2 57.5 7.7
53778281 L Tyrphostin AG 879 59.1 52.4 6.9 27.8 10.6 53.5 10.6 52.4 20.6
53777778 L (−)-Isoproterenol hydrochloride 69.4 52.2 9.3 66.2 7.2 25.2 22.2 52.2 16.6
53777840 L Metaproterenol hemisulfate 58.5 51.3 0.7 102.6 3.0 8.1 26.1 93.1 0.7
53777465 L (−)-α-methylnorepinephrine 55.8 51.2 9.1 68.1 3.3 27.4 16.0 12.7 6.2
53778191 L (±)-Synephrine 61.5 50.7 7.8 59.6 7.4 12.3 22.3 50.8 16.3
53777817 L (±)-Isoproterenol hydrochloride 63.4 50.3 2.6 63.9 3.3 17.8 20.7 32.1 33.1
53778152 L Cortexolone maleate 57.1 50.3 6.2 46.5 3.5 5.6 21.3 −35.5 30.4
53777595 L N-(3,3-diphenylpropyl)glycinamide 61.0 49.6 11.6 62.6 2.7 9.3 15.4 34.3 5.8
53778147 L Ritodrine hydrochloride 63.1 49.0 2.6 69.7 12.7 −3.1 17.6 48.0 7.9
53778120 L Propantheline bromide 57.0 47.7 9.9 53.4 3.0 11.7 26.7 35.6 8.2
46386828 N Balsalazida 58.5 47.1 3.0 53.1 4.0 10.0 29.3 15.4 25.4
53778232 L Terbutaline hemisulfate 61.4 46.3 6.1 97.6 2.6 −12.4 16.9 78.4 8.3
53778036 L Perphenazine 73.3 46.2 2.8 87.3 7.7 50.9 8.5 68.5 0.7
53777521 L 6,7-ADTN hydrobromide 52.8 45.7 6.3 50.4 9.4 19.1 19.6 32.8 3.6
53777200 L L(−)-Norepinephrine bitartrate 55.8 40.5 10.9 61.9 2.2 34.3 23.7 39.1 10.9
46387005 N Salmeterol 63.2 38.5 4.8 110.4 1.4 2.8 26.3 90.0 1.9
53777665 L Guanidinyl-naltrindole di-trifluoroacetate 57.8 36.8 12.2 52.7 5.2 −13.6 10.0 −15.3 7.6
53777160 L Aurintricarboxylic acid 86.3 36.5 5.4 105.0 0.8 99.4 0.2 98.6 2.5
53777487 L 8-Cyclopentyl-1,3-dipropylxanthine 52.1 33.8 10.6 60.6 4.6 23.8 15.0 26.6 18.3
53777634 L cis-(Z)-flupenthixol dihydrochloride 79.0 30.8 10.1 72.3 5.3 13.3 13.2 15.5 23.4
53777608 L (−)-Epinephrine bitartrate 62.1 24.7 11.4 58.0 7.4 1.6 16.5 11.1 15.7
53777159 L (±)-Norepinephrine (+)bitartrate 69.5 24.4 7.6 62.1 2.2 43.4 12.2 45.6 11.0

HCS data represent % inhibition of a single well, confirmation data represent mean % inhibition±SD (n=3), 1 and 24 h of compound exposure data presented.

SID, PubChem substance identifier, SL, source library, L, LOPAC, N, NIH CC.